Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a mid-stage trial, as the company plans to adjust dosing.

Discontinuation rates soar The high rate of discontinuation among GLP-1 users remains a prime burden to keeping patients on the drugs.

CVS Pharmacy has announced plans to rebrand 20 Bartell Drugs locations as part of its acquisition strategy in the Pacific Northwest, the company confirmed Friday.

CVS plans to rebrand 20 Bartell Drugs stores in Washington amid its acquisition of Rite Aid locations. The future of other Bartell stores remains uncertain.

As many had expected, all remaining Bartell Drugs locations will be converted to CVS, which is purchasing the stores from Bartell's bankrupt corporate parent, Rite Aid.

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo resolved its shortage.

9amHealth has a new partnership with Mark Cuban Cost Plus Drugs to help members afford obesity medications.

Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster treatment, an early-stage trial showed, as the drugmaker races to develop ...